The fact that both AML M6 and M7, which herein have the highest levels of ALDH1A1 RNA expression level, have a very poor prognosis [72] necessitates follow-up research that increases the effectiveness of targeting AML cells. This evidence concerns the gene ALDH1A1 and acute myeloid leukemia.